Efficacy of STI571 for a patient with metastatic gastrointestinal stromal tumor

Hepatogastroenterology. 2005 Nov-Dec;52(66):1764-7.

Abstract

A 65-year-old man was referred to our hospital for evaluation of his huge abdominal tumor. He was diagnosed as having a gastrointestinal stromal tumor arising from the stomach. Seven months after surgery, multiple liver metastases and mesenteric dissemination occurred. He was medicated with STI571, which works by blocking proliferation of malignant cells with expression of c-kit. The tumors shrank and serum lactate dehydrogenase and alkaline phosphatase concentrations fell to below the normal limit three months later. STI571 was effective medicine for the metastatic gastrointestinal stromal tumor for six months in this case.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Benzamides
  • Biopsy, Needle
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Fatal Outcome
  • Gastrointestinal Neoplasms / drug therapy*
  • Gastrointestinal Neoplasms / pathology*
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / pathology*
  • Humans
  • Imatinib Mesylate
  • Immunohistochemistry
  • Male
  • Neoplasm Staging
  • Palliative Care*
  • Piperazines / administration & dosage*
  • Pyrimidines / administration & dosage*
  • Risk Assessment
  • Time Factors
  • Tomography, X-Ray Computed

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate